GoodRx Holdings, Inc. GDRX Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by GoodRx Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about GoodRx Holdings, Inc.'s total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GoodRx Holdings, Inc.'s total costs & expenses?
- GoodRx Holdings, Inc. (GDRX) reported total costs & expenses of $180M in Q1 2026.
- How has GoodRx Holdings, Inc.'s total costs & expenses changed year-over-year?
- GoodRx Holdings, Inc.'s total costs & expenses increased by 0.2% year-over-year, from $179.59M to $180M.
- What is the long-term trend for GoodRx Holdings, Inc.'s total costs & expenses?
- Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s total costs & expenses has grown at a -0.8% compound annual growth rate (CAGR), from $732.02M to $709.36M.
- What does total costs & expenses mean?
- This metric represents the aggregate sum of all operating and non-operating costs incurred by the company to generate revenue and maintain business operations during a specific period. It encompasses cost of revenue, research and development, sales and marketing, general and administrative expenses, and depreciation and amortization. Monitoring this figure allows investors to evaluate the company's overall cost structure and operational efficiency relative to its total revenue generation.